Regulation of Cell and Gene Therapies in Canada

In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society (2022)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,923

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Cell and Gene Therapy Product Regulation in China.Yingying Liu, Linxi Wu Murphy Mao & Anette Hjelmsmark - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.
A Defense of Limited Regulation of Human Genetic Therapies.James J. Hughes - 2019 - Cambridge Quarterly of Healthcare Ethics 28 (1):112-120.
Ownership issues in autologous stem cell therapies.Patrick Foong Chee Kuen - 2019 - Eubios Journal of Asian and International Bioethics 29 (6):186-190.
Special Considerations for Cell-Based Advanced Therapies.Bridget Bulwer, Mo Heidaran & Darin J. Weber - 2022 - In William Sietsema & Jocelyn Jennings (eds.), Regulation of regenerative medicines: a global perspective. Rockville: Regulatory Affairs Professionals Society.

Analytics

Added to PP
2023-12-24

Downloads
0

6 months
0

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references